Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study
Kaili Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yunbo Zhao(University of Science and Technology of China), Shikai Wu(Hebei Medical University), Xuan Jin(Peking University), Wei Deng(Capital Medical University), Yang Ge(Merck & Co., Inc., Rahway, NJ, USA (United States)), Qin Li(Capital Medical University), Yusheng Wang(Hunan Agricultural University), Yan Dong(Beijing Luhe Hospital Affiliated to Capital Medical University), Yan Zhang(Wuhan University), Jinghua Sun(Dalian Medical University), Lu Han(Liaoning Cancer Hospital & Institute), Zhiqiang Cheng(China-Japan Friendship Hospital), Lin Zhao(Shandong University), Chuanhua Zhao(Chinese PLA General Hospital), Xiujuan Qu(First Hospital of China Medical University), Yuwei Hua(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Zhou(Sichuan Agricultural University)
Cited by 30
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion
|Cell Research|2013|395
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
|Cephalalgia|2011|263
Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer
|European Radiology|2019|198